Tyrphostin A1CAS# 2826-26-8 |
2D Structure
- AMG-208
Catalog No.:BCC1054
CAS No.:1002304-34-8
- SGX-523
Catalog No.:BCC1055
CAS No.:1022150-57-7
- PHA-665752
Catalog No.:BCC1181
CAS No.:477575-56-7
- SU11274
Catalog No.:BCC1243
CAS No.:658084-23-2
- Cabozantinib (XL184, BMS-907351)
Catalog No.:BCC1264
CAS No.:849217-68-1
Quality Control & MSDS
3D structure
Package In Stock
Number of papers citing our products
Cas No. | 2826-26-8 | SDF | Download SDF |
PubChem ID | 2063 | Appearance | Powder |
Formula | C11H8N2O | M.Wt | 184.19 |
Type of Compound | N/A | Storage | Desiccate at -20°C |
Synonyms | Tyrphostin 1; AG9 | ||
Solubility | DMSO : ≥ 100 mg/mL (542.92 mM) *"≥" means soluble, but saturation unknown. | ||
Chemical Name | 2-[(4-methoxyphenyl)methylidene]propanedinitrile | ||
SMILES | COC1=CC=C(C=C1)C=C(C#N)C#N | ||
Standard InChIKey | UOHFCPXBKJPCAD-UHFFFAOYSA-N | ||
Standard InChI | InChI=1S/C11H8N2O/c1-14-11-4-2-9(3-5-11)6-10(7-12)8-13/h2-6H,1H3 | ||
General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months. Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it. |
||
About Packaging | 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial. 2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial. 3. Try to avoid loss or contamination during the experiment. |
||
Shipping Condition | Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request. |
Tyrphostin A1 Dilution Calculator
Tyrphostin A1 Molarity Calculator
1 mg | 5 mg | 10 mg | 20 mg | 25 mg | |
1 mM | 5.4292 mL | 27.1459 mL | 54.2918 mL | 108.5835 mL | 135.7294 mL |
5 mM | 1.0858 mL | 5.4292 mL | 10.8584 mL | 21.7167 mL | 27.1459 mL |
10 mM | 0.5429 mL | 2.7146 mL | 5.4292 mL | 10.8584 mL | 13.5729 mL |
50 mM | 0.1086 mL | 0.5429 mL | 1.0858 mL | 2.1717 mL | 2.7146 mL |
100 mM | 0.0543 mL | 0.2715 mL | 0.5429 mL | 1.0858 mL | 1.3573 mL |
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations. |
Calcutta University
University of Minnesota
University of Maryland School of Medicine
University of Illinois at Chicago
The Ohio State University
University of Zurich
Harvard University
Colorado State University
Auburn University
Yale University
Worcester Polytechnic Institute
Washington State University
Stanford University
University of Leipzig
Universidade da Beira Interior
The Institute of Cancer Research
Heidelberg University
University of Amsterdam
University of Auckland
TsingHua University
The University of Michigan
Miami University
DRURY University
Jilin University
Fudan University
Wuhan University
Sun Yat-sen University
Universite de Paris
Deemed University
Auckland University
The University of Tokyo
Korea University
Tyrphostin A1(AG9) inhibits CD40L-stimulated IL-12 production in macrophage cultures and antigen-induced generation of Th1 cells. IC50 value: Target: IL-12 production inhibitor Addition of increasing concentration of A1 resulted in a dose dependent decrease of IL-12 p40, with maximal inhibition (62.5%) occurring at a dose of 10 μM. tyrphostin A1 blocks CD40L-induced translocation of NF-κB to the nucleus, and reduces the activation of IL-12 p40 gene. In vivo therapy with A1 leads to decrease in generation of myelin basic protein (MBP) specific encephalitogenic T cells. In addition, treatment of SJL/J mice with A1 results in attenuation of experimental allergic encephalomyelitis (EAE) [1]. Tyrphostin A1 is a much weaker inhibitor of TK than other tyrphostins (IC50>1250 μM for epidermal growth factor receptor (EGFR) kinase), and therefore often used to differentiate TK-mediated effects of tyrphostins from other non-specific effects [2].
References:
[1]. Du C, et al. Inhibition of CD40 signaling pathway by tyrphostin A1 reduces secretion of IL-12 in macrophage, Th1 cell development and experimental allergic encephalomyelitis in SJL/J mice. J Neuroimmunol. 2001 Mar 1;114(1-2):69-79.
[2]. Ogura T, et al. Activation of background membrane conductance by the tyrosine kinase inhibitor tyrphostin A23 and its inactive analog tyrphostin A1 in guinea pig ventricular myocytes. Jpn J Pharmacol. 2001 Nov;87(3):235-9.
- Reynosin
Catalog No.:BCN5178
CAS No.:28254-53-7
- HOOBt
Catalog No.:BCC2817
CAS No.:28230-32-2
- Phlorin
Catalog No.:BCN5177
CAS No.:28217-60-9
- JTE 907
Catalog No.:BCC7380
CAS No.:282089-49-0
- Lauterine
Catalog No.:BCN7062
CAS No.:28200-65-9
- Dihydrodehydrodiconiferyl alcohol
Catalog No.:BCN5176
CAS No.:28199-69-1
- Sinensin
Catalog No.:BCN4797
CAS No.:28189-90-4
- 5-Amino-2-mercaptobenzimidazole
Catalog No.:BCC8730
CAS No.:2818-66-8
- Futoquinol
Catalog No.:BCN6416
CAS No.:28178-92-9
- CHC
Catalog No.:BCC7994
CAS No.:28166-41-8
- Peonidin-3-O-galactoside chloride
Catalog No.:BCN3027
CAS No.:28148-89-2
- 8-Aminoadenine
Catalog No.:BCC6108
CAS No.:28128-33-8
- Baicalein 6-O-glucoside
Catalog No.:BCN3325
CAS No.:28279-72-3
- Beta-Elemonic acid
Catalog No.:BCN2981
CAS No.:28282-25-9
- Daurinoline
Catalog No.:BCN2742
CAS No.:2831-75-6
- 5-Hydroxy-1-tetralone
Catalog No.:BCN8397
CAS No.:28315-93-7
- Valifenalate
Catalog No.:BCC8071
CAS No.:283159-90-0
- Fmoc-ß-HoAsn(Trt)-OH
Catalog No.:BCC3228
CAS No.:283160-20-3
- Rucaparib (free base)
Catalog No.:BCC4012
CAS No.:283173-50-2
- 11beta-Hydroxycedrelone
Catalog No.:BCN5179
CAS No.:283174-18-5
- sn-Glycero-3-phosphocholine
Catalog No.:BCC4168
CAS No.:28319-77-9
- IVHD-valtrate
Catalog No.:BCN7125
CAS No.:28325-56-6
- 6-Ethoxydihydrosanguinarine
Catalog No.:BCN7589
CAS No.:28342-31-6
- Oxychelerythrine
Catalog No.:BCN4864
CAS No.:28342-33-8
Activation of background membrane conductance by the tyrosine kinase inhibitor tyrphostin A23 and its inactive analog tyrphostin A1 in guinea pig ventricular myocytes.[Pubmed:11885974]
Jpn J Pharmacol. 2001 Nov;87(3):235-9.
ABSTRACT-The effects of the tyrosine kinase (TK) inhibitor tyrphostin A23 and its inactive analog tyrphostin Al on background membrane conductance were investigated in guinea pig ventricular myocytes. TK-inhibiting A23 reversibly increased membrane conductance under conditions designed to minimize Na+, Ca2+, K+, and Na+-K+ pump currents. Similar stimulatory action was obtained with TK-inactive Al. The tyrphostin-induced current was inhibited by omitting external Na+ or Ca+, suppressed by chelating internal Ca2+, blocked by external Cd2+ and Ni2+, and insensitive to changes in internal Cl- concentration. We conclude that tyrphostins have a direct, TK-independent action that increases membrane conductance probably by stimulating Na+-Ca2+ exchange.
Inhibition of CD40 signaling pathway by tyrphostin A1 reduces secretion of IL-12 in macrophage, Th1 cell development and experimental allergic encephalomyelitis in SJL/J mice.[Pubmed:11240017]
J Neuroimmunol. 2001 Mar 1;114(1-2):69-79.
Activation of antigen presenting cells through the interaction of CD40 with its ligand is a critical co-stimulatory signal for IL-12 production and Th1 differentiation. Tyrphostins are organic molecules that inhibit the phosphorylation of protein tyrosine kinases. We show that Tyrphostin A1 inhibits CD40L-stimulated IL-12 production in macrophage cultures and antigen-induced generation of Th1 cells. Our data also show that Tyrphostin A1 blocks CD40L-induced translocation of NF-kappaB to the nucleus, and reduces the activation of IL-12 p40 gene. In vivo therapy with A1 leads to decrease in generation of myelin basic protein (MBP) specific encephalitogenic T cells. In addition, treatment of SJL/J mice with A1 results in attenuation of experimental allergic encephalomyelitis (EAE).